Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property magazine. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

  • Patent portfolio planning, strategic advice, opinions, and prosecution
  • Post-grant proceedings at the USPTO
  • Litigation services, including representation in Hatch-Waxman cases
  • FDA expertise
  • Counsel on licensing and other transactions

We have a rapidly expanding practice representing branded pharmaceutical companies in Hatch-Waxman litigation. Biotechnology and pharmaceutical companies trust Fish’s litigation team to handle these complicated, high-stakes cases because we are the world’s most experienced patent litigators.

Examples of our biotechnology and pharmaceutical work include:

  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Successfully litigating ANDA cases on behalf of branded pharmaceuticals
  • Obtaining patents for therapeutic agents and methods currently in clinical trials, including tumor-specific agents such as oncolytics viruses and humanized antibodies and methods for treating strokes
  • Patenting groundbreaking tissue engineering patents on breakthroughs that show promise in treating spinal cord injuries
  • Obtaining the first patent on a genetically engineered animal
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting intellectual property due diligence on thousands of licensing agreements for the merger of two large pharmaceuticals companies in just a few months’ time

Featured Experience

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Event
December 3rd, 2017
Consero 2017 IP Forum for Life Sciences
Consero 2017 IP Forum for Life Sciences
Speaking Engagement
Sponsorship
News
October 17, 2017
Fish & Richardson Principal Anita Meiklejohn, Ph.D., Named 2017 “Top Woman of Law” Honoree by Massachusetts Lawyers Weekly
Press Release
News
October 13, 2017
11 Fish & Richardson Principals Named 2017 "Life Sciences Stars" by LMG Life Sciences
Press Release
News
September 27, 2017
Fish & Richardson Announces Mayo/Myriad Life Sciences Tracker
Press Release
News
September 19, 2017
Fish & Richardson Named 2017 General Patent Litigation Firm of the Year, Inter Partes Review Firm of the Year, and IP Boutique Firm of the Year by LMG Life Sciences
Press Release
News
August 11, 2017
Star Tribune: Mayo prevails in patent case, but legal fight isn't over
Articles
News
August 11, 2017
Law360: Athena Diagnostic Test Patent Axed For Covering Natural Law
Articles
News
July 10, 2017
Fish & Richardson Sweeps National Tier 1 IP Rankings from Managing Intellectual Property for Seventh Consecutive Year
Press Release
Fish Patent Blog
June 19, 2017
Teresa Lavoie Interviewed by Metropolitan Corporate Counsel, "How a Patent Prosecutor/Strategic Adviser Racks Up Wins"
Teresa Lavoie Interviewed by <i>Metropolitan Corporate Counsel</i>,
Author: Teresa A. Lavoie, Ph.D.
Fish Patent Blog
June 14, 2017
Tasha Francis, Will Orlady and Dorothy Whelan Author NYIPLA Article, "Recent Developments in Biopharma PTAB Practice"
Tasha Francis, Will Orlady and Dorothy Whelan Author <i>NYIPLA</i> Article,
Authors: Will Orlady, Dorothy P. Whelan, Tasha M. Francis, Ph.D.
News
June 13, 2017
PTAB Rules in Favor of Fish Client Coherus BioSciences in Two More IPR Decisions
Articles
Fish Patent Blog
May 23, 2017
Xconomy: What's Hot in Boston Biotech
Xconomy: What's Hot in Boston Biotech
Author: Teresa A. Lavoie, Ph.D.
load more topics